Bone Biologics closes $7.9M public offering, uplists to Nasdaq Capital Market

Bone Biologics Corp

Completed public offering of 1,510,455 units at $5.25/unit for gross proceeds of $7.9M.
Each unit consists of one share of common stock and one warrant (exercise $6.30, 5-year term).
Warrants are immediately exercisable; underwriter has 45-day option for up to 226,568 additional shares/warrants.
Company effectuated a 1-for-2.5 reverse stock split effective Oct 12, 2021.
Shares and warrants began trading on Nasdaq Capital Market on Oct 13, 2021 under BBLG and BBLGW.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.